Graf Akcie NUS (Nu Skin Enterprises, Inc.). Diskuze k akciím NUS. Aktuální informace NUS.

Základní informace o společnosti Nu Skin Enterprises, Inc. (Akcie NUS)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 2.04B
Hodnota podniku (EV) 2.15B
Tržby 2.833B
EBITDA 385.771M
Zisk 236.542M
Růst v tržbách Q/Q 14.97 %
Růst v tržbách Y/Y 22.96 %
P/E (Cena vůči ziskům) 8.89
Forward P/E 27.43
EV/Sales 0.76
EV/EBITDA 5.58
EV/EBIT 6.90
PEG N/A
Price/Sales 0.72
P/FCF 14.29
Price/Book 2.28
Účetní hodnota na akcii 18.06
Hotovost na akcii 8.56
FCF vůči ceně 7.00 %
Počet zaměstnanců 2,020
Tržba na zaměstnance 1402000
Profit margin 7.41 %
Operating margin 10.99 %
Gross margin 74.51 %
EBIT margin 11.02 %
EBITDA margin 13.62 %
EPS - Zisk na akcii 4.64
EPS - Kvartální růst 41.98 %
EPS - Očekávaný růst příští rok 6.48 %
Return on assets 12.17 %
Return on equity 26.95 %
ROIC 13.75 %
ROCE 21.77 %
Dluhy/Equity 1.19
Čistý dluh/EBITDA 1.05
Current ratio 1.56
Quick Ratio 0.93
Volatilita 2.79
Beta 0.84
RSI 40.50
Cílová cena analytiků 63
Známka akcie (dle analytiků) 2.14
Insider ownership 1.63 %
Institutional ownership 83.04 %
Počet akcií 50.135M
Procento shortovaných akcií 6.66 %
Short ratio 5.32 %
Dividenda 1.52
Procentuální dividenda 3.72 %
Dividenda/Zisk 32.65 %
Obchodovaná od 1996
Země United States

Finanční výsledky akcie NUS

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$2,581.934$2,420.416$2,679.008$2,279.099$2,207.797$2,247.047
Cost Of Goods Sold$658.028$581.42$634.14$502.078$500.457$489.51
Gross Profit$1,923.906$1,838.996$2,044.868$1,777.021$1,707.34$1,757.537
Research And Development Expenses------
SG&A Expenses$1,666.342$1,571.57$1,733.322$1,502.538$1,476.236$1,512.835
Other Operating Income Or Expenses------
Operating Expenses$2,324.37$2,152.99$2,438.148$2,004.616$1,976.693$2,002.345
Operating Income$257.564$267.426$240.86$274.483$231.104$244.702
Total Non-Operating Income/Expense$-1.332$-12.254$-21.194$-8.916$-18.265$-32.743
Pre-Tax Income$256.232$255.172$219.666$265.567$212.839$211.959
Income Taxes$64.877$81.619$97.779$136.13$69.753$78.913
Income After Taxes$191.355$173.553$121.887$129.437$143.086$133.046
Other Income------
Income From Continuous Operations$191.355$173.553$121.887$129.437$143.086$133.046
Income From Discontinued Operations------
Net Income$191.355$173.553$121.887$129.437$143.086$133.046
EBITDA$331.555$344.076$323.863$346.047$303.501$316.067
EBIT$257.564$267.426$240.86$274.483$231.104$244.702
Basic Shares Outstanding525655535558
Shares Outstanding535656555659
Basic EPS$3.66$3.13$2.21$2.45$2.58$2.29
EPS - Earnings Per Share$3.63$3.10$2.16$2.36$2.55$2.25
# 2020 2019 2018 2017 2016 2015
Current Ratio1.66382.07471.81791.73861.79031.7331
Long-term Debt / Capital0.25460.27650.31590.30610.33480.1804
Debt/Equity Ratio0.3750.41350.55060.55160.62780.3023
Gross Margin74.514175.978576.329377.970377.332378.2154
Operating Margin9.975611.04888.990612.043510.467610.8899
EBIT Margin9.975611.04888.990612.043510.467610.8899
EBITDA Margin12.841314.215612.088915.183513.746814.0659
Pre-Tax Profit Margin9.92410.54258.199511.65239.64039.4328
Net Profit Margin7.41137.17044.54975.67936.48095.9209
Asset Turnover1.31931.36821.58111.43351.49781.4922
Inventory Turnover Ratio2.09322.10742.14371.98092.00231.8454
Receiveable Turnover40.743848.045150.279868.655870.76563.3614
Days Sales In Receivables8.95847.5977.25945.31645.15795.7606
ROE - Return On Equity21.397919.828115.589218.370421.546816.1147
Return On Tangible Equity31.799229.003124.608524.796629.468120.5901
ROA - Return On Assets9.77769.81087.19338.14139.7078.8353
ROI - Return On Investment15.950714.346210.66512.747614.333913.2073
Book Value Per Share17.569215.742614.113113.369912.60114.7432
Operating Cash Flow Per Share4.004-0.4083-1.9260.6089-0.54736.3816
Free Cash Flow Per Share3.9757-0.3436-2.07530.4074-0.48377.0894